Difference between revisions of "Template:Article of the week"

From LIMSWiki
Jump to navigationJump to search
(Updated article of the week text)
(Updated article of the week text)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig2 Oyashi GeospatialHlth2019 14-1.png|240px]]</div>
'''"[[Journal:Next steps for access to safe, secure DNA synthesis|Next steps for access to safe, secure DNA synthesis]]"'''
'''"[[Journal:Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study|Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study]]"'''


Since the 1970s, Earth-observing satellites collect increasingly detailed [[Environmental monitoring|environmental information]] on land cover, meteorological conditions, environmental variables, and air pollutants. This [[information]] spans the entire globe, and its acquisition plays an important role in epidemiological analysis when ''in situ'' data are unavailable or spatially and/or temporally sparse. In this paper, we present the development of the Japan Aerospace Exploration Agency’s (JAXA) Public-health Monitoring and Analysis Platform, a user-friendly, web-based system providing environmental data on shortwave radiation, rainfall, soil moisture, the normalized difference vegetation index, aerosol optical thickness, land surface temperature and altitude. ('''[[Journal:Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study|Full article...]]''')<br />
The [[DNA synthesis]] industry has, since the invention of gene-length synthesis, worked proactively to ensure synthesis is carried out securely and safely. Informed by guidance from the U.S. government, several of these companies have collaborated over the last decade to produce a set of best practices for customer and sequence screening prior to manufacture. Taken together, these practices ensure that synthetic DNA is used to advance research that is designed and intended for public benefit. With increasing scale in the industry and expanding capability in the synthetic biology toolset, it is worth revisiting current practices to evaluate additional measures to ensure the continued safety and wide availability of DNA synthesis. Here we encourage specific steps, in part derived from successes in the [[cybersecurity]] community, that can ensure synthesis screening systems stay well ahead of emerging challenges, to continue to enable responsible research advances. [[Artificial gene synthesis|Gene synthesis]] companies, science and technology funders, policymakers, and the scientific community as a whole have a shared duty to continue to minimize risk and maximize the safety and security of DNA synthesis to further power world-changing developments in advanced biological manufacturing, agriculture, drug development, healthcare, and energy. ('''[[Journal:Next steps for access to safe, secure DNA synthesis|Full article...]]''')<br />
<br />
<br />
''Recently featured'':
''Recently featured'':
: ▪ [[Journal:Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study|Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study]]
: ▪ [[Journal:Smart grids and ethics: A case study|Smart grids and ethics: A case study]]
: ▪ [[Journal:Smart grids and ethics: A case study|Smart grids and ethics: A case study]]
: ▪ [[Journal:Heart failure and healthcare informatics|Heart failure and healthcare informatics]]
: ▪ [[Journal:Heart failure and healthcare informatics|Heart failure and healthcare informatics]]
: ▪ [[Journal:Cyberbiosecurity for biopharmaceutical products|Cyberbiosecurity for biopharmaceutical products]]

Revision as of 14:22, 16 September 2019

"Next steps for access to safe, secure DNA synthesis"

The DNA synthesis industry has, since the invention of gene-length synthesis, worked proactively to ensure synthesis is carried out securely and safely. Informed by guidance from the U.S. government, several of these companies have collaborated over the last decade to produce a set of best practices for customer and sequence screening prior to manufacture. Taken together, these practices ensure that synthetic DNA is used to advance research that is designed and intended for public benefit. With increasing scale in the industry and expanding capability in the synthetic biology toolset, it is worth revisiting current practices to evaluate additional measures to ensure the continued safety and wide availability of DNA synthesis. Here we encourage specific steps, in part derived from successes in the cybersecurity community, that can ensure synthesis screening systems stay well ahead of emerging challenges, to continue to enable responsible research advances. Gene synthesis companies, science and technology funders, policymakers, and the scientific community as a whole have a shared duty to continue to minimize risk and maximize the safety and security of DNA synthesis to further power world-changing developments in advanced biological manufacturing, agriculture, drug development, healthcare, and energy. (Full article...)

Recently featured:

Japan Aerospace Exploration Agency’s public-health monitoring and analysis platform: A satellite-derived environmental information system supporting epidemiological study
Smart grids and ethics: A case study
Heart failure and healthcare informatics